| NCT ID | NCT07501299 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HeartBeam, Inc. |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2026-03-30 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2026-03-30 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The HeartBeam ECG Registry will collect ECG recordings acquired with the HeartBeam System with relevant clinical information in clinical settings.
Eligibility Criteria
Inclusion Criteria: 1. Undergoing ECG as part of standard of care. 2. Able and willing to provide written informed consent. Exclusion Criteria: 1. Open chest wounds or surgery to the chest or abdomen within 30 days. 2. Inability to complete ECG acquisition with either HeartBeam device or standard 12-L ECG. 3. Unstable condition where registry participation may interfere with care.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07501299 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07501299 currently recruiting?
Yes, NCT07501299 is actively recruiting participants. Contact the research team at pchatterjee@heartbeam.com for enrollment information.
Where is the NCT07501299 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07501299 clinical trial?
NCT07501299 is sponsored by HeartBeam, Inc.. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.